The DOI matches its Crossref record.
Multidrug-Resistant Tuberculosis in Patients without HIV Infection
Open accessAbstract
BACKGROUND: Investigations of outbreaks of multidrug-resistant tuberculosis have found low rates of treatment response and very high mortality, and they have mainly involved patients with advanced human immunodeficiency virus (HIV) infection. For patients without HIV infection, one study reported an overall rate of response to treatment of 56 percent, and the mortality from tuberculosis was 22 percent. We investigated treatment response and mortality rates in 26 HIV-negative patients in New York with multidrug-resistant tuberculosis. METHODS: We obtained detailed data from seven teaching hospitals in New York City on patients with multidrug-resistant tuberculosis--defined as tuberculosis resistant at least to isoniazid and rifampin--who were HIV-negative on serologic testing. Lengths of times from diagnosis to the initiation of appropriate therapy and from the initiation of appropriate therapy to conversion to negative cultures were assessed. Therapeutic responses were evaluated by both microbiologic and clinical criteria. RESULTS: Between March 1991 and September 1994, 26 HIV-negative patients were identified and treated. Of the 25 patients for whom adequate data were available for analysis, 24 (96 percent) had clinical responses; all 17 patients for whom data on microbiologic response were available had such a response. The median times from diagnosis to the initiation of appropriate therapy and from the initiation of therapy to culture conversion were 44 days (range, 0 to 181) and 69 days (range, 2 to 705), respectively. Side effects requiring the discontinuation of medication occurred in 4 of 23 patients (17 percent) who were treated with second-line antituberculosis medications. The median follow-up for the 23 patients who responded and who received appropriate therapy was 91 weeks (range, 41 to 225). CONCLUSIONS: In this report from New York City, HIV-negative patients with multidrug-resistant tuberculosis, contrary to previous reports, responded well to appropriate chemotherapy, both clinically and microbiologically.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Espinal, M. A., Kim, S. J., Suarez, P. G., Kam, K. M., Khomenko, A. G., Migliori, G. B., Baéz, J., Kochi, A., Dye, C., & Raviglione, M. C. (2000) · JAMA · doi:10.1001/jama.283.19.2537 · Cited by 507
Mutations in Putative Mutator Genes of Mycobacterium tuberculosis Strains of the W-Beijing Family
Ebrahimi-Rad, M., Bifani, P., Martin, C., Kremer, K., Samper, S., Rauzier, J., Kreiswirth, B., Blazquez, J., Jouan, M., van Soolingen, D., et al. (2003) · Emerging Infectious Diseases · doi:10.3201/eid0907.020803 · Cited by 288
Treatment of Comorbid Tuberculosis and Depression
Trenton, A. J., & Currier, G. W. (2001) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.v03n0610 · Cited by 48
Blaya, J. A., Shin, S. S., Yagui, M., Contreras, C., Cegielski, P., Yale, G., Suarez, C., Asencios, L., Bayona, J., Kim, J., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090110 · Cited by 36
Metadata
- Authors
- Telzak, E. E., Sepkowitz, K., Alpert, P., Mannheimer, S., Medard, F., El-Sadr, W., Blum, S., Gagliardi, A., Salomon, N., & Turett, G.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1995-10-05
- Volume
- 333
- Issue
- 14
- Pages
- 907-912
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2020481446
- Cited by
- 208
- References
- 0
- FWCI
- 10.62
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Multidrug-Resistant Tuberculosis in Patients without HIV Infection. https://app.cochat.ai/papers/10.1056/nejm199510053331404
- The paper
- Telzak, E. E., Sepkowitz, K., Alpert, P., Mannheimer, S., Medard, F., El-Sadr, W., Blum, S., Gagliardi, A., Salomon, N., & Turett, G. (1995). Multidrug-Resistant Tuberculosis in Patients without HIV Infection. New England Journal of Medicine. https://doi.org/10.1056/nejm199510053331404
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.